Retinoic Acid Therapy and Regulation of Salivary and Serum IL-1β, IL-8 and MCP-1 Levels

NCT06879795 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2025-03-17

No results posted yet for this study

Summary

This prospective cohort study analysed the effects of systemic retinoic acid use on periodontal status, salivary flow rate (SFR), and salivary and serum levels of interleukin (IL)-1β, IL-8 and monocyte chemoattractant protein (MCP)-1.

Conditions

  • Acne Vulgaris
  • Gingivitis and Periodontal Diseases
  • Saliva Collection
  • Inflammation Biomarkers
  • Vitamin A

Sponsors & Collaborators

  • Medipol University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2024-07-01
Completion
2024-07-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06879795 on ClinicalTrials.gov